User profiles for Kathleen Montone
Kathleen MontoneUniverstiy of Pennsylvania Verified email at upenn.edu Cited by 12637 |
[PDF][PDF] Comprehensive genomic characterization of long non-coding RNAs across human cancers
…, K Hua, Y Lu, D Katsaros, Q Huang, K Montone… - Cancer cell, 2015 - cell.com
The discovery of long non-coding RNA (lncRNA) has dramatically altered our understanding
of cancer. Here, we describe a comprehensive analysis of lncRNA alterations at …
of cancer. Here, we describe a comprehensive analysis of lncRNA alterations at …
[PDF][PDF] Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors
…, J Conejo-Garcia, HR Ramay, KT Montone… - Cancer cell, 2019 - cell.com
We investigated the role of chemokines in regulating T cell accumulation in solid tumors.
CCL5 and CXCL9 overexpression was associated with CD8 + T cell infiltration in solid tumors. …
CCL5 and CXCL9 overexpression was associated with CD8 + T cell infiltration in solid tumors. …
[HTML][HTML] Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers
Aldehyde dehydrogenase isoform 1 (ALDH1) has been proved useful for the identification
of cancer stem cells. However, our knowledge of the expression and activity of ALDH1 in …
of cancer stem cells. However, our knowledge of the expression and activity of ALDH1 in …
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult …
…, BG Somer, SJ Schuster, DL Porter, KT Montone… - …, 2001 - journals.lww.com
Background. Posttransplant lymphoproliferative disorder (PTLD) is an Epstein-Barr virus–associated
malignancy that occurs in the setting of pharmacologic immunosuppression after …
malignancy that occurs in the setting of pharmacologic immunosuppression after …
[PDF][PDF] A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer
…, S Jean, C Li, Q Huang, D Katsaros, KT Montone… - Cancer cell, 2014 - cell.com
In a genome-wide survey on somatic copy-number alterations (SCNAs) of long noncoding
RNA (lncRNA) in 2,394 tumor specimens from 12 cancer types, we found that about 21.8% of …
RNA (lncRNA) in 2,394 tumor specimens from 12 cancer types, we found that about 21.8% of …
[PDF][PDF] Serotonin reduction in post-acute sequelae of viral infection
Post-acute sequelae of COVID-19 (PASC, "Long COVID") pose a significant global health
challenge. The pathophysiology is unknown, and no effective treatments have been found to …
challenge. The pathophysiology is unknown, and no effective treatments have been found to …
Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop.
…, W Ngo, TL Pasha, KT Montone… - The American journal …, 1995 - ncbi.nlm.nih.gov
The neuroendocrine hormone prolactin is a growth factor required for the proliferation and
terminal differentiation of the human breast. These effects are mediated by the prolactin …
terminal differentiation of the human breast. These effects are mediated by the prolactin …
Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer
Long noncoding RNAs (lncRNAs) play critical roles during tumorigenesis by functioning as
scaffolds that regulate protein-protein, protein-DNA or protein-RNA interactions. Using a …
scaffolds that regulate protein-protein, protein-DNA or protein-RNA interactions. Using a …
Histology and histomorphometry of ethmoid bone in chronic rhinosinusitis
…, BA Senior, FH Gannon, KT Montone… - The …, 1998 - Wiley Online Library
Mucosal changes have been well described in chronic sinusitis, yet little is known about the
underlying bone, despite clinical and experimental evidence suggesting that bone may be …
underlying bone, despite clinical and experimental evidence suggesting that bone may be …
Expression of prolactin and its receptor in human breast carcinoma
C Reynolds, KT Montone, CM Powell… - …, 1997 - academic.oup.com
The growth regulatory effects of PRL on the human breast are mediated by its receptor (PRLr),
a member of the cytokine receptor family. Recent reverse transcriptase-PCR studies by …
a member of the cytokine receptor family. Recent reverse transcriptase-PCR studies by …